Hackman Jeffrey S. bought FENC
February 18, 2026 · Form 4 insider transaction
Hackman Jeffrey S. bought 13,710 shares of Fennec Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
13,710
Price
$0.00
Total value
N/A
InsiderHackman Jeffrey S.
RoleOfficer, Director
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateFebruary 18, 2026
Filing dateFebruary 19, 2026
Shares owned after28,710
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents settlement of PSUs that vested on February 18, 2026.